Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

By Moton Allen   Krishna Gopal   Ma Lei   O’Mara Edward   Prasad Pratapa   McLeod James   Preston Richard A.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 937-945

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pharmacokinetics of peginterferon lambda‐1a following single dose administration to subjects with impaired renal function

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 3, 2015-09 ,pp. : 515-524

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 6, 2015-06 ,pp. : 698-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Equivalent Dynamic Human Brain NK1‐Receptor Occupancy Following Single‐Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite